TCR-T cell therapy (TCRx Therapeutics)

N/A

Report date: 2023/04/14 20:00:48

Base Information

Drug NameTCR-T cell therapy (TCRx Therapeutics)
Drug Alias NameKSX01-TCRT
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTCRx Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTCRx Therapeutics Co LtdTrishula Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A